Haidl P, Heindl S, Siemon K, Bernacka M, Cloes RM. Inhalation device requirements for patients’ inhalation maneuvers. Respir Med. 2016;118:65–75.

Article  PubMed  Google Scholar 

Alagusundaram M, Deepthi N, Ramkanth S, Angalaparameswari S, Saleem TM, Gnanaprakash K, et al. Dry powder inhalers-An overview. Int J Pharm Sci Res. 2010;1(1):34–42.

CAS  Google Scholar 

Chrystyn H, Niederlaender C. The Genuair® inhaler: a novel, multidose dry powder inhaler. Int J Clin Pract. 2012;66(3):309–17.

Article  CAS  PubMed  Google Scholar 

Chrystyn H. The DiskusTM: a review of its position among dry powder inhaler devices. Int J Clin Pract. 2007;61(6):1022–36.

Article  CAS  PubMed  Google Scholar 

Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–8.

Article  PubMed  Google Scholar 

Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. European Respiratory Society; 2011.

Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101(11):2395–401.

Article  PubMed  Google Scholar 

Chrystyn H, Price D. What you need to know about inhalers and how to use them. Prescriber. 2009;20(12):47–52.

Article  Google Scholar 

Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Int J Chron Obstruct Pulmon Dis. 2019. https://doi.org/10.2147/COPD.S195438.

Article  PubMed  PubMed Central  Google Scholar 

EAC Broeders M, Vincken W, Corbetta L. The ADMIT series—issues in inhalation therapy. 7) Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique. Prim Care Respir J. 2011;20(3):338–43.

Article  PubMed Central  Google Scholar 

Dougall S, Bolt J, Semchuk W, Winkel T. Inhaler assessment in COPD patients: a primer for pharmacists. Can Pharm J. 2016;149(5):268–73.

Article  Google Scholar 

Ali AM, Zawbaa HM, Sayed OM, Harb HS, Saeed H, Boshra MS, et al. In vitro and in vivo performance modelling and optimisation of different dry powder inhalers: a complementary study of neural networks, genetic algorithms and decision trees. Int J Clin Pract. 2021;75(3): e13764.

Article  CAS  PubMed  Google Scholar 

Abdelrahman MA, Saeed H, Osama H, Harb HS, Madney YM, Abdelrahim ME. Effect of verbal counselling on metred-dose inhaler proper use and lung function test amongst asthmatic patients: a meta-analysis. Int J Clin Pract. 2021;75(6): e14077.

Article  CAS  PubMed  Google Scholar 

Ghosh S, Ohar JA, Drummond MB. Peak inspiratory flow rate in chronic obstructive pulmonary disease: implications for dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2017;30(6):381–7.

Article  PubMed  PubMed Central  Google Scholar 

Yawn BP, Colice GL, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2012. https://doi.org/10.2147/COPD.S32674.

Article  PubMed  PubMed Central  Google Scholar 

Harb HS, Ibrahim Laz N, Rabea H, Abdelrahim ME. Real-life assessment of chronic obstructive pulmonary disease patient performance with different inhalers. Int J Clin Pract. 2021;75(4): e13905.

Article  CAS  PubMed  Google Scholar 

Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19:1–20.

Article  Google Scholar 

Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A, et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017. https://doi.org/10.1183/13993003.01794-2016.

Article  PubMed  Google Scholar 

Souza MLdM, Meneghini AC, Vianna EO, Borges MC. Knowledge of and technique for using inhalation devices among asthma patients and COPD patients. J Bras Pneumol. 2009;35:824–31.

Article  PubMed  Google Scholar 

Harb HS, Ibrahim Laz N, Rabea H, Abdelrahim ME. Determinants of incorrect inhaler technique in chronic obstructive pulmonary disease patients. Int J Clin Pract. 2021;75(6): e14073.

Article  CAS  PubMed  Google Scholar 

Harb HS, Laz NI, Rabea H, Abdelrahim ME. First-time handling of different inhalers by chronic obstructive lung disease patients. Exp Lung Res. 2020;46(7):258–69.

Article  CAS  PubMed  Google Scholar 

Palander A, Mattila T, Karhu M, Muttonen E. In vitro comparison of three salbutamol-containing multidose dry powder inhalers: Buventol Easyhaler®, Inspiryl Turbuhaler® and Ventoline Diskus®. Clin Drug Investig. 2000;20:25–33.

Article  CAS  Google Scholar 

Ali AMA, Abdelrahim MEA. Modeling and optimization of terbutaline emitted from a dry powder inhaler and influence on systemic bioavailability using data mining technology. J Pharm Innov. 2014;9:38–47.

Article  Google Scholar 

Broeders M, Molema J, Vermue N, Folgering HTM. Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers. Eur Respir J. 2001;18(5):780–3.

Article  CAS  PubMed  Google Scholar 

Amirav I, Newhouse MT, Mansour Y. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol. 2005;39(5):447–51.

Article  PubMed  Google Scholar 

Mahler DA. Peak inspiratory flow rate as a criterion for dry powder inhaler use in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(7):1103–7.

PubMed  Google Scholar 

Pavia D, Thomson ML, Clarke SW, Shannon HS. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax. 1977;32(2):194–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis1-3. Am Rev Respir Dis. 1987;136(6):1445–9.

Article  CAS  PubMed  Google Scholar 

Dolovich M, Nahmias C, Coates G. Unleashing the PET: 3D imaging of the lung. In: Byron PR, Dalby R, Farr SJ, editors. Respiratory Drug Delivery VII. Raleigh, NC: Serentec Press; 2000. p. 215–30.

Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56(6):588–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S-Y, Huang C-K, Peng H-C, Yu C-J, Chien J-Y. Inappropriate peak inspiratory flow rate with dry powder inhaler in chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):7271.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harb HS, Elberry AA, Rabea H, Fathy M, Abdelrahim ME. Is combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation? J Drug Deliv Sci Technol. 2017;40:28–34.

Article  CAS  Google Scholar 

Harb HS, Elberry AA, Rabea H, Fathy M, Abdelrahim ME. Performance of large spacer versus nebulizer T-piece in single-limb noninvasive ventilation. Respir Care. 2018;63(11):1360–9.

Article  PubMed  Google Scholar 

Sanders MJ. Guiding inspiratory flow: development of the in-check DIAL G16, a tool for improving inhaler technique. Pulm Med. 2017;2017:1495867.

Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation [see comments]. Br J Clin Pharmacol. 1992;34(4):311–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silkstone V, Dennis J, Pieron C, Chrystyn H. An investigation of in vitro/in vivo correlations for salbutamol nebulized by eight systems. J Aerosol Med. 2002;15(3):251–9.

Article